The global Marginal Zone B-cell Lymphoma Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Marginal zone lymphoma (MZL) is?a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL cases. The average age at diagnosis is 60 years, and it is slightly more common in women than in men.
This report aims to provide a comprehensive presentation of the global market for Marginal Zone B-cell Lymphoma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marginal Zone B-cell Lymphoma Drugs. This report contains market size and forecasts of Marginal Zone B-cell Lymphoma Drugs in global, including the following market information:
- Global Marginal Zone B-cell Lymphoma Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Epclusa Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Marginal Zone B-cell Lymphoma Drugs include Gilead Sciences, Roche, Amgen, Biocad, Cadila Pharmaceuticals, Celltrion, Dr Reddy?s Laboratories, Teva and Hetero Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Marginal Zone B-cell Lymphoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Marginal Zone B-cell Lymphoma Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Marginal Zone B-cell Lymphoma Drugs Market Segment Percentages, by Type, 2022 (%)
- Epclusa
- Rituximab
- Lenalidomide
- Zanubrutinib
- Ibritumomab Tiuxetan
Global Marginal Zone B-cell Lymphoma Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Marginal Zone B-cell Lymphoma Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Marginal Zone B-cell Lymphoma Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Marginal Zone B-cell Lymphoma Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Marginal Zone B-cell Lymphoma Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Marginal Zone B-cell Lymphoma Drugs revenues share in global market, 2022 (%)
Key players include:
- Gilead Sciences
- Roche
- Amgen
- Biocad
- Cadila Pharmaceuticals
- Celltrion
- Dr Reddy?s Laboratories
- Teva
- Hetero Group
- Zenotech Laboratories
- Celgene
- AbbVie
- BioVision
- Selleck Chemicals
- Biosynth Carbosynth
- LifeSpan BioSciences
- Clearsynth
- CASI Pharmaceuticals
- Biogen
- Bayer
- Spectrum
- Shuanglu Pharmaceutical
- Qilu Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Marginal Zone B-cell Lymphoma Drugs, market overview.
Chapter 2: Global Marginal Zone B-cell Lymphoma Drugs market size in revenue.
Chapter 3: Detailed analysis of Marginal Zone B-cell Lymphoma Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Marginal Zone B-cell Lymphoma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Marginal Zone B-cell Lymphoma Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Marginal Zone B-cell Lymphoma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Marginal Zone B-cell Lymphoma Drugs Overall Market Size
2.1 Global Marginal Zone B-cell Lymphoma Drugs Market Size: 2022 VS 2030
2.2 Global Marginal Zone B-cell Lymphoma Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Marginal Zone B-cell Lymphoma Drugs Players in Global Market
3.2 Top Global Marginal Zone B-cell Lymphoma Drugs Companies Ranked by Revenue
3.3 Global Marginal Zone B-cell Lymphoma Drugs Revenue by Companies
3.4 Top 3 and Top 5 Marginal Zone B-cell Lymphoma Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Marginal Zone B-cell Lymphoma Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Marginal Zone B-cell Lymphoma Drugs Players in Global Market
3.6.1 List of Global Tier 1 Marginal Zone B-cell Lymphoma Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Marginal Zone B-cell Lymphoma Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Marginal Zone B-cell Lymphoma Drugs Market Size Markets, 2022 & 2030
4.1.2 Epclusa
4.1.3 Rituximab
4.1.4 Lenalidomide
4.1.5 Zanubrutinib
4.1.6 Ibritumomab Tiuxetan
4.2 By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue & Forecasts
4.2.1 By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2023
4.2.2 By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2024-2030
4.2.3 By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Marginal Zone B-cell Lymphoma Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue & Forecasts
5.2.1 By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2023
5.2.2 By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2024-2030
5.2.3 By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Marginal Zone B-cell Lymphoma Drugs Market Size, 2022 & 2030
6.2 By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue & Forecasts
6.2.1 By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2023
6.2.2 By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2024-2030
6.2.3 By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030
6.3.2 US Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.3.3 Canada Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.3.4 Mexico Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030
6.4.2 Germany Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.3 France Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.4 U.K. Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.5 Italy Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.6 Russia Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.4.8 Benelux Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030
6.5.2 China Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.5.3 Japan Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.5.4 South Korea Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.5.6 India Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030
6.6.2 Brazil Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.6.3 Argentina Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030
6.7.2 Turkey Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.7.3 Israel Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
6.7.5 UAE Marginal Zone B-cell Lymphoma Drugs Market Size, 2018-2030
7 Marginal Zone B-cell Lymphoma Drugs Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.1.4 Gilead Sciences Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.2.4 Roche Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.3.4 Amgen Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Biocad
7.4.1 Biocad Company Summary
7.4.2 Biocad Business Overview
7.4.3 Biocad Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.4.4 Biocad Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.4.5 Biocad Key News & Latest Developments
7.5 Cadila Pharmaceuticals
7.5.1 Cadila Pharmaceuticals Company Summary
7.5.2 Cadila Pharmaceuticals Business Overview
7.5.3 Cadila Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.5.4 Cadila Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.5.5 Cadila Pharmaceuticals Key News & Latest Developments
7.6 Celltrion
7.6.1 Celltrion Company Summary
7.6.2 Celltrion Business Overview
7.6.3 Celltrion Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.6.4 Celltrion Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.6.5 Celltrion Key News & Latest Developments
7.7 Dr Reddy?s Laboratories
7.7.1 Dr Reddy?s Laboratories Company Summary
7.7.2 Dr Reddy?s Laboratories Business Overview
7.7.3 Dr Reddy?s Laboratories Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.7.4 Dr Reddy?s Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.7.5 Dr Reddy?s Laboratories Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.8.4 Teva Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Hetero Group
7.9.1 Hetero Group Company Summary
7.9.2 Hetero Group Business Overview
7.9.3 Hetero Group Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.9.4 Hetero Group Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.9.5 Hetero Group Key News & Latest Developments
7.10 Zenotech Laboratories
7.10.1 Zenotech Laboratories Company Summary
7.10.2 Zenotech Laboratories Business Overview
7.10.3 Zenotech Laboratories Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.10.4 Zenotech Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.10.5 Zenotech Laboratories Key News & Latest Developments
7.11 Celgene
7.11.1 Celgene Company Summary
7.11.2 Celgene Business Overview
7.11.3 Celgene Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.11.4 Celgene Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.11.5 Celgene Key News & Latest Developments
7.12 AbbVie
7.12.1 AbbVie Company Summary
7.12.2 AbbVie Business Overview
7.12.3 AbbVie Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.12.4 AbbVie Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.12.5 AbbVie Key News & Latest Developments
7.13 BioVision
7.13.1 BioVision Company Summary
7.13.2 BioVision Business Overview
7.13.3 BioVision Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.13.4 BioVision Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.13.5 BioVision Key News & Latest Developments
7.14 Selleck Chemicals
7.14.1 Selleck Chemicals Company Summary
7.14.2 Selleck Chemicals Business Overview
7.14.3 Selleck Chemicals Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.14.4 Selleck Chemicals Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.14.5 Selleck Chemicals Key News & Latest Developments
7.15 Biosynth Carbosynth
7.15.1 Biosynth Carbosynth Company Summary
7.15.2 Biosynth Carbosynth Business Overview
7.15.3 Biosynth Carbosynth Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.15.4 Biosynth Carbosynth Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.15.5 Biosynth Carbosynth Key News & Latest Developments
7.16 LifeSpan BioSciences
7.16.1 LifeSpan BioSciences Company Summary
7.16.2 LifeSpan BioSciences Business Overview
7.16.3 LifeSpan BioSciences Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.16.4 LifeSpan BioSciences Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.16.5 LifeSpan BioSciences Key News & Latest Developments
7.17 Clearsynth
7.17.1 Clearsynth Company Summary
7.17.2 Clearsynth Business Overview
7.17.3 Clearsynth Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.17.4 Clearsynth Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.17.5 Clearsynth Key News & Latest Developments
7.18 CASI Pharmaceuticals
7.18.1 CASI Pharmaceuticals Company Summary
7.18.2 CASI Pharmaceuticals Business Overview
7.18.3 CASI Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.18.4 CASI Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.18.5 CASI Pharmaceuticals Key News & Latest Developments
7.19 Biogen
7.19.1 Biogen Company Summary
7.19.2 Biogen Business Overview
7.19.3 Biogen Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.19.4 Biogen Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.19.5 Biogen Key News & Latest Developments
7.20 Bayer
7.20.1 Bayer Company Summary
7.20.2 Bayer Business Overview
7.20.3 Bayer Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.20.4 Bayer Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.20.5 Bayer Key News & Latest Developments
7.21 Spectrum
7.21.1 Spectrum Company Summary
7.21.2 Spectrum Business Overview
7.21.3 Spectrum Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.21.4 Spectrum Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.21.5 Spectrum Key News & Latest Developments
7.22 Shuanglu Pharmaceutical
7.22.1 Shuanglu Pharmaceutical Company Summary
7.22.2 Shuanglu Pharmaceutical Business Overview
7.22.3 Shuanglu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.22.4 Shuanglu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.22.5 Shuanglu Pharmaceutical Key News & Latest Developments
7.23 Qilu Pharmaceutical
7.23.1 Qilu Pharmaceutical Company Summary
7.23.2 Qilu Pharmaceutical Business Overview
7.23.3 Qilu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Major Product Offerings
7.23.4 Qilu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue in Global Market (2018-2023)
7.23.5 Qilu Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Marginal Zone B-cell Lymphoma Drugs Market Opportunities & Trends in Global Market
Table 2. Marginal Zone B-cell Lymphoma Drugs Market Drivers in Global Market
Table 3. Marginal Zone B-cell Lymphoma Drugs Market Restraints in Global Market
Table 4. Key Players of Marginal Zone B-cell Lymphoma Drugs in Global Market
Table 5. Top Marginal Zone B-cell Lymphoma Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Marginal Zone B-cell Lymphoma Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Marginal Zone B-cell Lymphoma Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Marginal Zone B-cell Lymphoma Drugs Product Type
Table 9. List of Global Tier 1 Marginal Zone B-cell Lymphoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Marginal Zone B-cell Lymphoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Marginal Zone B-cell Lymphoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Marginal Zone B-cell Lymphoma Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Marginal Zone B-cell Lymphoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Marginal Zone B-cell Lymphoma Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Gilead Sciences Company Summary
Table 31. Gilead Sciences Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 32. Gilead Sciences Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 36. Roche Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 40. Amgen Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Biocad Company Summary
Table 43. Biocad Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 44. Biocad Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Biocad Key News & Latest Developments
Table 46. Cadila Pharmaceuticals Company Summary
Table 47. Cadila Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 48. Cadila Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Cadila Pharmaceuticals Key News & Latest Developments
Table 50. Celltrion Company Summary
Table 51. Celltrion Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 52. Celltrion Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Celltrion Key News & Latest Developments
Table 54. Dr Reddy?s Laboratories Company Summary
Table 55. Dr Reddy?s Laboratories Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 56. Dr Reddy?s Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Dr Reddy?s Laboratories Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 60. Teva Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Key News & Latest Developments
Table 62. Hetero Group Company Summary
Table 63. Hetero Group Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 64. Hetero Group Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Hetero Group Key News & Latest Developments
Table 66. Zenotech Laboratories Company Summary
Table 67. Zenotech Laboratories Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 68. Zenotech Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Zenotech Laboratories Key News & Latest Developments
Table 70. Celgene Company Summary
Table 71. Celgene Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 72. Celgene Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Celgene Key News & Latest Developments
Table 74. AbbVie Company Summary
Table 75. AbbVie Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 76. AbbVie Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. AbbVie Key News & Latest Developments
Table 78. BioVision Company Summary
Table 79. BioVision Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 80. BioVision Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. BioVision Key News & Latest Developments
Table 82. Selleck Chemicals Company Summary
Table 83. Selleck Chemicals Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 84. Selleck Chemicals Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Selleck Chemicals Key News & Latest Developments
Table 86. Biosynth Carbosynth Company Summary
Table 87. Biosynth Carbosynth Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 88. Biosynth Carbosynth Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Biosynth Carbosynth Key News & Latest Developments
Table 90. LifeSpan BioSciences Company Summary
Table 91. LifeSpan BioSciences Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 92. LifeSpan BioSciences Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. LifeSpan BioSciences Key News & Latest Developments
Table 94. Clearsynth Company Summary
Table 95. Clearsynth Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 96. Clearsynth Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Clearsynth Key News & Latest Developments
Table 98. CASI Pharmaceuticals Company Summary
Table 99. CASI Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 100. CASI Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. CASI Pharmaceuticals Key News & Latest Developments
Table 102. Biogen Company Summary
Table 103. Biogen Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 104. Biogen Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Biogen Key News & Latest Developments
Table 106. Bayer Company Summary
Table 107. Bayer Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 108. Bayer Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Bayer Key News & Latest Developments
Table 110. Spectrum Company Summary
Table 111. Spectrum Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 112. Spectrum Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Spectrum Key News & Latest Developments
Table 114. Shuanglu Pharmaceutical Company Summary
Table 115. Shuanglu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 116. Shuanglu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Shuanglu Pharmaceutical Key News & Latest Developments
Table 118. Qilu Pharmaceutical Company Summary
Table 119. Qilu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Product Offerings
Table 120. Qilu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Qilu Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Marginal Zone B-cell Lymphoma Drugs Segment by Type in 2022
Figure 2. Marginal Zone B-cell Lymphoma Drugs Segment by Application in 2022
Figure 3. Global Marginal Zone B-cell Lymphoma Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Marginal Zone B-cell Lymphoma Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Marginal Zone B-cell Lymphoma Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Marginal Zone B-cell Lymphoma Drugs Revenue in 2022
Figure 8. By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 16. US Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 28. China Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Marginal Zone B-cell Lymphoma Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Marginal Zone B-cell Lymphoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Gilead Sciences Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biocad Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cadila Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celltrion Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dr Reddy?s Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hetero Group Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zenotech Laboratories Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Celgene Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AbbVie Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. BioVision Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Selleck Chemicals Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Biosynth Carbosynth Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. LifeSpan BioSciences Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Clearsynth Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. CASI Pharmaceuticals Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Biogen Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Bayer Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Spectrum Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Shuanglu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Qilu Pharmaceutical Marginal Zone B-cell Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
